NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 56 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $36,000 | +176.9% | 262,523 | +102.7% | 0.00% | – |
| Q4 2018 | $13,000 | -58.1% | 129,497 | -3.3% | 0.00% | – |
| Q3 2018 | $31,000 | -26.2% | 133,905 | -26.5% | 0.00% | – |
| Q2 2018 | $42,000 | -33.3% | 182,135 | +3.4% | 0.00% | – |
| Q1 2018 | $63,000 | +53.7% | 176,143 | +54.8% | 0.00% | – |
| Q4 2017 | $41,000 | +141.2% | 113,798 | +179.7% | 0.00% | – |
| Q3 2017 | $17,000 | -34.6% | 40,688 | -19.7% | 0.00% | – |
| Q2 2017 | $26,000 | -35.0% | 50,659 | -27.1% | 0.00% | – |
| Q1 2017 | $40,000 | -52.4% | 69,495 | -23.6% | 0.00% | – |
| Q3 2016 | $84,000 | +1100.0% | 91,010 | +563.2% | 0.00% | – |
| Q2 2016 | $7,000 | -41.7% | 13,723 | +11.8% | 0.00% | – |
| Q1 2016 | $12,000 | -76.9% | 12,279 | -68.5% | 0.00% | – |
| Q4 2015 | $52,000 | -14.8% | 39,033 | +46.1% | 0.00% | – |
| Q3 2015 | $61,000 | -65.7% | 26,719 | -71.6% | 0.00% | – |
| Q4 2014 | $178,000 | +1012.5% | 94,219 | +699.9% | 0.00% | – |
| Q3 2014 | $16,000 | -15.8% | 11,779 | -7.3% | 0.00% | – |
| Q2 2014 | $19,000 | +1800.0% | 12,707 | +2932.7% | 0.00% | – |
| Q1 2014 | $1,000 | -98.9% | 419 | -99.1% | 0.00% | – |
| Q4 2013 | $94,000 | +34.3% | 45,485 | +71.0% | 0.00% | – |
| Q3 2013 | $70,000 | +438.5% | 26,598 | +451.3% | 0.00% | – |
| Q2 2013 | $13,000 | – | 4,825 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|